Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum

Journal of Neuroscience

Volumn 25, Issue 22, 2005, Pages 5273-5279

  Thiriet, Nathalie ^a   Deng, Xiaolin ^b   Solinas, Marcello ^a,b   Ladenheim, Bruce ^b   Curtis, Wendy ^c   Goldberg, Steven R ^b   Palmiter, Richard D ^c   Cadet, Jean Lud ^b  

^a UNIVERSITÉ DE POITIERS   (France)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamines; Cell death; Neurodegenerative diseases; Neuroprotection; NPY; Y2 receptor

Indexed keywords

ENKEPHALIN; ILLICIT DRUG; MESSENGER RNA; METHAMPHETAMINE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DRUG PROTEIN BINDING; GENE EXPRESSION; HUNTINGTON CHOREA; INTERNEURON; MALE; MOUSE; NERVE PROJECTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STRESS;

ANIMALS; APOPTOSIS; CORPUS STRIATUM; ENKEPHALINS; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; METHAMPHETAMINE; MICE; MICE, KNOCKOUT; NEURONS; NEUROPEPTIDE Y; NITRIC OXIDE SYNTHASE; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER; STREET DRUGS;

EID: 20044382059     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4893-04.2005     Document Type: Article

References (57)

1. Ali SF, Newport GD, Holson RR, Slikker Jr W, Bowyer JF (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-38.
2. Battaglia G, Fornai F, Busceti CL, Aloisi G, Cerrito F, De Blasi A, Melchiorri D, Nicoletti F (2002) Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity. J Neurosci 22:2135-2141.
3. Beal MF, Ferrante RJ, Swartz KJ, Kowall NW (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J Neurosci 11:1649-1659.
4. Behrens MI, Koh JY, Muller MC, Choi DV (1996) NADPH diaphorase-containing striatal or cortical neurons are resistant to apoptosis. Neurobiol Dis 3:72-75.
5. Bouali SM, Fournier A, St-Pierre S, Jolicoeur FB (1995) Influence of ambient temperature on the effects of NPY on body temperature and food intake. Pharmacol Biochem Behav 50:473-475.
6. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker Jr W, Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1580.
7. Brown PL, Wise RA, Kiyatkin EA (2003) Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction. J Neurosci 23:3924-3929.
8. Caberlotto L, Fuxe K, Hurd YL (2000) Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum. J Chem Neuroanat 20:327-337.
9. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383.
10. Cadet JL, Jayanthi S, Deng X (2003) Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminals degeneration and neuronal apoptosis. FASEB J 17:1775-1788.
11. Davidson C, Gow AJ, Lee TH, Ellinwood EH (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 36:1-22.
12. de la Monte SM, Vonsattel JP, Richardson Jr EP (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 47:516-525.
13. Deng X, Cadet JL (1999) Methamphetamine administration causes overexpression of nNOS in the mouse striatum. Brain Res 851:254-257.
14. Deng X, Cadet JL (2000) Methamphetamine-induced apoptosis is attenuated in the striata of copper-zinc superoxide dismutase transgenic mice. Brain Res Mol Brain Res 83:121-124.
15. Deng X, Ladenheim B, Tsao LI, Cadet JL (1999) Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci 19:10107-10115.
16. Deng X, Jayanthi S, Ladenheim B, Krasnova IN, Cadet JL (2002) Mice with partial deficiency of c-Jun show attenuation of methamphetamine-induced neuronal apoptosis. Mol Pharmacol 62:993-1000.
17. Ellison G, Switzer RC (1993) Dissimilar patterns of degeneration in brain following four different addictive stimulants. NeuroReport 5:17-20.
18. Erickson JC, Clegg KE, Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-421.
19. Escalante OD, Ellinwood EHJ (1970) Central nervous system cytopathological changes with chronic methedrine intoxication. Brain Res 21:151-155.
20. 2+ and phospholipase C. Brain Res 958:43-51.
21. Ferrante RJ, Kowall NW, Beal MF, Richardson Jr EP, Bird ED, Martin JB (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230:561-563.
22. Ferri KF, Kroemer G (2001) Organelle-specific initiation of cell death pathways. Nat Cell Biol 3:E255-E263.
23. Ferriero DM, Arcavi LJ, Sagar SM, McIntosh TK, Simon RP (1988) Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia-ischemia. Ann Neurol 24:670-676.
24. Freese TE, Miotto K, Reback CI (2002) The effects and consequences of selected club drugs. J Subst Abuse Treat 23:151-156.
25. Gonzales C, Lin RC, Chesselet MF (1992) Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions. Neurosci Lett 135:53-58.
26. Gonzalez-Zulueta M, Ensz LM, Mukhina G, Lebovitz RM, Zwacka RM, Engelhardt JF, Oberley LW, Dawson VL, Dawson TM (1998) Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J Neurosci 18:2040-2055.
27. Grundemar L, Hakanson R (1994) Neuropeptide Y effector systems: perspectives for drug development. Trends Pharmacol Sci 15:153-159.
28. Halladay AK, Kusnecov A, Michna L, Kita T, Hara C, Wagner GC (2003) Relationship between methamphetamine-induced dopamine release, hyperthermia, self-injurious behaviour and long term dopamine depletion in BALB/c and C57BL/6 mice. Pharmacol Toxicol 93:33-41.
29. Hansel DE, Eipper BA, Ronnett GV (2001) Neuropeptide Y functions as a neuroproliferative factor. Nature 410:940-944.
30. Inagaki S, Takagi H, Suzuki K, Akai F, Taniguchi N (1991a) Intense immunoreactivity for Mn-superoxide dismutase (Mn-SOD) in cholinergic and non-cholinergic neurons in the rat basal forebrain. Brain Res 541:354-357.
31. Inagaki S, Suzuki K, Taniguchi N, Takagi H (1991b) Localization of Mn-superoxide dismutase (Mn-SOD) in cholinergic and somatostatin-containing neurons in the rat neostriatum. Brain Res 549:174-177.
32. Jayanthi S, Ladenheim B, Cadet JL (1998) Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann NY Acad Sci 844:92-102.
33. Jayanthi S, Deng X, Noailles PA, Ladenheim B, Cadet JL (2004) Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J 18:238-251.
34. Jayanthi S, Deng X, Ladenheim B, McCoy MT, Cluster A, Cai NS, Cadet JL (2005) Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc Natl Acad Sci USA 102:868-873.
35. Kawaguchi Y (1997) Neostriatal cell subtypes and their functional roles. Neurosci Res 27:1-8.
36. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC (1995) Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 18:527-535.
37. Keffel S, Schmidt M, Bischoff A, Michel MC (1999) Neuropeptide-Y stimulation of extracellular signal-regulated kinases in human erythroleukemia cells. J Pharmacol Exp Ther 291:1172-1178.
38. Koh JY, Peters S, Choi DW (1986) Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. Science 234:73-76.
39. Lee HJ, Bach JH, Chae HS, Lee SH, Joo WS, Choi SH, Kim KY, Lee WB, Kim SS (2004) Mitogen-activated protein kinase/extracellular signal-regulated kinase attenuates 3-hydroxykynurenine-induced neuronal cell death. J Neurochem 88:647-656.
40. Mannon PJ, Raymond JR (1998) The neuropeptide Y/peptide YY Y1 receptor is coupled to MAP kinase via PKC and Ras in CHO cells. Biochem Biophys Res Commun 246:91-94.
41. Maragos WF, Jakel R, Chesnut D, Pocernich CB, Butterfield DA, St Clair D, Cass WA (2000) Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Res 878:218-222.
42. Mitchell IJ, Cooper AJ, Griffiths MR (1999) The selective vulnerability of striatopallidal neurons. Prog Neurobiol 59:691-719.
43. Mullins DE, Zhang X, Hawes BE (2002) Activation of extracellular signal regulated protein kinase by neuropeptide Y and pancreatic polypeptide in CHO cells expressing the NPY Y(1), Y(2), Y(4) and Y(5) receptor subtypes. Regul Pept 105:65-73.
44. Naveilhan P, Neveu I, Arenas E, Ernfors P (1998) Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience 87:289-302.
45. Pedrazzini T, Pralong F, Grouzmann E (2003) Neuropeptide Y: the universal soldier. Cell Mol Life Sci 60:350-377.
46. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85:5733-5737.
47. Richard D (1995) Exercise and the neurobiological control of food intake and energy expenditure. Int J Obes Relat Metab Disord 19 [Suppl 4]:S73-S79.
48. Silva AP, Carvalho AP, Carvalho CM, Malva JO (2001) Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J Neurochem 79:286-296.
49. Silva AP, Cavadas C, Grouzmann E (2002) Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326:3-25.
50. Silva AP, Pinheiro PS, Carvalho AP, Carvalho CM, Jakobsen B, Zimmer J, Malva JO (2003) Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J 17:1118-1120.
51. Thiriet N, Ladenheim B, McCoy MT, Cadet JL (2002) Analysis of ecstasy (MDMA)-induced transcriptional responses in the rat cortex. FASEB J 16:1887-1894.
52. 2+ oscillations in the VTA dopamine neurons. NeuroReport 11:1057-1061.
53. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Wong C, Logan J (2001) Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry 158:383-389.
54. Westwood SC, Hanson GR (1999) Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems. J Pharmacol Exp Ther 288:1160-1166.
55. Wettstein JG, Earley B, Junien JL (1995) Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther 65:397-414.
56. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699-703.
57. Zalis EG, Lundberg GD, Knutson RA (1967) The pathophysiology of acute amphetamine poisoning with pathologic correlation. J Pharmacol Exp Ther 158:115-127.